Inactive Instrument

Other languages Antares

Equities

Antares : utile netto adj. 2021 cresce a 28,3 mln (24,7 mln in 2020)	22-03-07
L'agenda di oggi	22-03-07
L'agenda della prossima settimana	22-03-04
Antares : sospende periodo esercizio conversione dei Warrant	22-03-03
Antares Pharma Posts Higher Q4 Adjusted Earnings, Revenue; Issues 2022 Revenue Guidance	22-03-03
Earnings Flash (ATRS) ANTARES PHARMA Reports Q4 Revenue $48.7M, vs. Street Est of $47.2M	22-03-03
Immo-Antares NV Reports Earnings Results for the Full Year Ended November 10, 2021	22-02-23
Antares : perfeziona acquisizione Acsis per 12 mln usd	22-02-18
Antares : accordo per acquisire Acsis	22-02-14
Antares Pharma's New Drug Application Resubmission for Testosterone Replacement Therapy Receives FDA Acceptance	22-02-03
Antares Vision : nuovo capitale sociale pari a 169.452 euro	22-02-02
Antares V. : Applied Vision scelta per installazioni in Turchia	22-01-25
Antares Pharma Secures FDA Fast Track Designation for ATRS-1902 in Acute Adrenal Insufficiency	22-01-18
Antares Pharma Says its Early-Stage Study of ATRS-1902 for Acute Adrenal Insufficiency Met its Primary Objective	22-01-11
Borsa I. : 2021 è anno record con 49 Ipo	21-12-30
Assertio Therapeutics Acquires Otrexup from Antares Pharma for $44 Million	21-12-16
Exclusive-Canada's CPP Investments seeks to sell insurance groups in strategy U-turn -sources	21-12-08
Hogere huurinkomsten voor Inclusio dan voorzien	21-11-18
Antares Vision : 3* trim. ricavi pari a 44 mln (+24% a/a)	21-11-12
L'agenda di oggi	21-11-12

No results for this search